At least 6 million people have died from COVID-19 to date. But who dies is often not random. The same pattern is found around the world.
Feb 15, 2023
0
28
In a test of antiviral effectiveness against the virus that causes COVID-19, an extract from edible seaweeds substantially outperformed remdesivir, the current standard antiviral used to combat the disease. Heparin, a common ...
Jul 24, 2020
0
1121
Scientists investigating why people who have had shingles are at a higher risk of stroke, now believe the answer lies within lipid vesicles called exosomes that shuttle proteins and genetic information between cells, according ...
Oct 28, 2022
0
1470
Researchers at King's College London, Massachusetts General Hospital and health science company ZOE have developed an artificial intelligence diagnostic that can predict whether someone is likely to have COVID-19 based on ...
May 11, 2020
0
326
University of New Mexico researchers who combed through a "library" of previously approved drugs believe they have identified a medication with the potential to help speed a patient's recovery from SARS-CoV-2 infection.
Oct 16, 2020
0
223
Early in the pandemic, many researchers feared people who contracted COVID could be reinfected very quickly. This was because several early studies showed antibodies seemed to wane after the first few months post-infection.
Nov 26, 2020
0
28
After analyzing the blood of a survivor of the 2013-16 Ebola outbreak, a team of scientists from academia, industry and the government has discovered the first natural human antibodies that can neutralize and protect animals ...
May 18, 2017
0
2180
New details surfaced on Thursday on an unexplained neurological condition that struck a volunteer who was participating in AstraZeneca's coronavirus vaccine trial.
Sep 18, 2020
0
23
Many Pennsylvania residents are facing an increased risk for severe symptoms of the novel coronavirus, while having limited access to medical services, and policy briefs from Penn State's Pennsylvania Population Network (PPN) ...
Apr 23, 2020
0
28
Mutations to the spike protein of the omicron variant are shown to alter how the virus infects cells and reduce its sensitivity to therapeutic and vaccine-elicited antibodies, according to a paper published in Nature. Booster ...
Feb 3, 2022
0
35
